[HTML][HTML] Mechanisms of chemotherapy-induced peripheral neuropathy
R Zajączkowska, M Kocot-Kępska, W Leppert… - International journal of …, 2019 - mdpi.com
Chemotherapy-induced peripheral neuropathy (CIPN) is one of the most frequent side
effects caused by antineoplastic agents, with a prevalence from 19% to over 85%. Clinically …
effects caused by antineoplastic agents, with a prevalence from 19% to over 85%. Clinically …
[HTML][HTML] Chemotherapy-induced peripheral neuropathy: epidemiology, pathomechanisms and treatment
J Burgess, M Ferdousi, D Gosal, C Boon… - Oncology and …, 2021 - Springer
Purpose This review provides an update on the current clinical, epidemiological and
pathophysiological evidence alongside the diagnostic, prevention and treatment approach …
pathophysiological evidence alongside the diagnostic, prevention and treatment approach …
[HTML][HTML] Long-term effects, pathophysiological mechanisms, and risk factors of chemotherapy-induced peripheral neuropathies: a comprehensive literature review
N Kerckhove, A Collin, S Condé, C Chaleteix… - Frontiers in …, 2017 - frontiersin.org
Neurotoxic anticancer drugs, such as platinum-based anticancer drugs, taxanes, vinca
alkaloids, and proteasome/angiogenesis inhibitors are responsible for chemotherapy …
alkaloids, and proteasome/angiogenesis inhibitors are responsible for chemotherapy …
Chemotherapy‐induced peripheral neurotoxicity: a critical analysis
With a 3‐fold increase in the number of cancer survivors noted since the 1970s, there are
now over 28 million cancer survivors worldwide. Accordingly, there is a heightened …
now over 28 million cancer survivors worldwide. Accordingly, there is a heightened …
Image-based consensus molecular subtype (imCMS) classification of colorectal cancer using deep learning
K Sirinukunwattana, E Domingo, SD Richman… - Gut, 2021 - gut.bmj.com
Objective Complex phenotypes captured on histological slides represent the biological
processes at play in individual cancers, but the link to underlying molecular classification …
processes at play in individual cancers, but the link to underlying molecular classification …
[PDF][PDF] Chemotherapy-induced neuropathy and its association with quality of life among 2-to 11-year colorectal cancer survivors: results from the population-based …
F Mols, T Beijers, V Lemmens… - J Clin …, 2013 - cris.maastrichtuniversity.nl
Chemotherapy-induced neuropathy and its association with quality of life among 2-to 11-year
colorectal cancer survivors: results from the population-based PROFILES registry Page 38 …
colorectal cancer survivors: results from the population-based PROFILES registry Page 38 …
Platinum‐induced peripheral neurotoxicity: from pathogenesis to treatment
NP Staff, G Cavaletti, B Islam… - Journal of the …, 2019 - Wiley Online Library
Platinum‐induced peripheral neurotoxicity (PIPN) is a common side effect of platinum‐
based chemotherapy that may cause dose reduction and discontinuation, with oxaliplatin …
based chemotherapy that may cause dose reduction and discontinuation, with oxaliplatin …
Hemoglobin, body mass index, and age as risk factors for paclitaxel-and oxaliplatin-induced peripheral neuropathy
Importance Chemotherapy-induced peripheral neuropathy (CIPN) is a debilitating adverse
effect of neurotoxic cancer treatments including taxanes and platinum agents. Limited …
effect of neurotoxic cancer treatments including taxanes and platinum agents. Limited …
A systematic review on chronic oxaliplatin-induced peripheral neuropathy and the relation with oxaliplatin administration
AJM Beijers, F Mols, G Vreugdenhil - Supportive Care in Cancer, 2014 - Springer
Purpose The aim of this study was to systematically review the literature on the influence of
oxaliplatin administration (eg cumulative dose, dose intensity, number of cycles and …
oxaliplatin administration (eg cumulative dose, dose intensity, number of cycles and …
Symptom experiences in colorectal cancer survivors after cancer treatments: a systematic review and meta-analysis
CJ Han, GS Yang, K Syrjala - Cancer Nursing, 2020 - journals.lww.com
Background With improved survivorship rates for colorectal cancer (CRC), more CRC
survivors are living with long-term disease and treatment side effects. Little research exists …
survivors are living with long-term disease and treatment side effects. Little research exists …